The Current and Promising Oral Delivery Methods for Protein- and Peptide-Based Drugs

被引:11
|
作者
Nicze, Michal [1 ]
Borowka, Maciej [1 ]
Dec, Adrianna [1 ]
Niemiec, Aleksandra [1 ]
Buldak, Lukasz [1 ]
Okopien, Boguslaw [1 ]
机构
[1] Med Univ Silesia, Fac Med Sci, Dept Internal Med & Clin Pharmacol, Medykow 18, PL-40752 Katowice, Poland
关键词
peptide- and protein-based drug; oral drug absorption; permeation enhancers; hydrogels; microneedles; semaglutide; octreotide; desmopressin; cyclosporine; CELL-PENETRATING PEPTIDES; CYCLOSPORINE-A; IN-VITRO; CARDIOVASCULAR OUTCOMES; GASTROINTESTINAL MUCUS; INTESTINAL-ABSORPTION; TRYPSIN-INHIBITOR; TIGHT JUNCTIONS; HUMAN INSULIN; NANOPARTICLES;
D O I
10.3390/ijms25020815
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Drugs based on peptides and proteins (PPs) have been widely used in medicine, beginning with insulin therapy in patients with diabetes mellitus over a century ago. Although the oral route of drug administration is the preferred one by the vast majority of patients and improves compliance, medications of this kind due to their specific chemical structure are typically delivered parenterally, which ensures optimal bioavailability. In order to overcome issues connected with oral absorption of PPs such as their instability depending on digestive enzymes and pH changes in the gastrointestinal (GI) system on the one hand, but also their limited permeability across physiological barriers (mucus and epithelium) on the other hand, scientists have been strenuously searching for novel delivery methods enabling peptide and protein drugs (PPDs) to be administered enterally. These include utilization of different nanoparticles, transport channels, substances enhancing permeation, chemical modifications, hydrogels, microneedles, microemulsion, proteolytic enzyme inhibitors, and cell-penetrating peptides, all of which are extensively discussed in this review. Furthermore, this article highlights oral PP therapeutics both previously used in therapy and currently available on the medical market.
引用
收藏
页数:29
相关论文
共 50 条
  • [21] Potential of Peptide-Based Enhancers for Transdermal Delivery
    Lopes, Luciana B.
    Carvalho, Vanessa F. M.
    de Lemos, Debora P.
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (20) : 2814 - 2822
  • [22] Functional peptide-based drug delivery systems
    Lian, Zheng
    Ji, Tianjiao
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (31) : 6517 - 6529
  • [23] Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin
    Gallo, Enrico
    Diaferia, Carlo
    Rosa, Elisabetta
    Smaldone, Giovanni
    Morelli, Giancarlo
    Accardo, Antonella
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2021, 16 : 1617 - 1630
  • [24] Advances in peptide-based drug delivery systems
    Guo, Sijie
    Wang, Jing
    Wang, Qi
    Wang, Jinxin
    Qin, Song
    Li, Wenjun
    HELIYON, 2024, 10 (04)
  • [25] Peptide-based supramolecular hydrogels for delivery of biologics
    Li, Yi
    Wang, Feihu
    Cui, Honggang
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2016, 1 (03) : 306 - 322
  • [26] Peptide-Based Matrices as Drug Delivery Vehicles
    Ezzat, Kariem
    El Andaloussi, Samir
    Abdo, Rania
    Langel, Ulo
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (09) : 1167 - 1178
  • [27] Peptide-based delivery of therapeutics in cancer treatment
    Samec, Timothy
    Boulos, Jessica
    Gilmore, Serena
    Hazelton, Anthony
    Alexander-Bryant, Angela
    MATERIALS TODAY BIO, 2022, 14
  • [28] Anti-cancer peptides: their current trends in the development of peptide-based therapy and anti-tumor drugs
    Lath, Amit
    Santal, Anita Rani
    Kaur, Nameet
    Kumari, Poonam
    Singh, Nater Pal
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2022, 39 (01) : 45 - 84
  • [29] Peptide-Based Inhibitors of the Induced Signaling Protein Interactions: Current State and Prospects
    Toshchakov, Vladimir Y.
    BIOCHEMISTRY-MOSCOW, 2024, 89 (05) : 784 - 798
  • [30] Peptide-Based Supramolecular Hydrogels as Drug Delivery Agents: Recent Advances
    Oliveira, Carlos B. P.
    Gomes, Valeria
    Ferreira, Paula M. T.
    Martins, Jose A.
    Jervis, Peter J.
    GELS, 2022, 8 (11)